Skip to main content
. 2020 Mar 31;21(7):2431. doi: 10.3390/ijms21072431
AA anthranilic acid
amyloid-β
AD Alzheimer’s disease
AhR aryl hydrocarbon receptor
AIDS acquired immune deficiency syndrome
ALS amyotrophic lateral sclerosis
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
APC antigen-presenting cell
ASC apoptosis-associated speck-like protein containing caspase activation and recruitment domains
BBB blood–brain barrier
CA cinnabarinic acid
CD cluster of differentiation
Cdh1 cadherin 1
CARD caspase activation and recruitment domains
cART combination antiretroviral therapies
CCL5 C–C motif chemokine ligand 5
CJD Creutzfeldt–Jakob disease
CNS central nervous system
CSF cerebrospinal fluid
DLB dementia with Lewy bodies
GC glucocorticoid
GPR35 G-protein-coupled receptor 35
3-HAA 3-hydroxy-anthralinic acid
HAND HIV-associated neurocognitive disorders
HD Huntington’s disease
HIV human immunodeficiency virus
3-HK 3-hydroxy-kynurenine
IFN interferon
LB Lewy body
IL interleukin
KAT kynurenine aminotransferase
KMO kynurenine-3-monooxygenase
KYN kynurenine
KYNA kynurenic acid
MIP macrophage inflammatory proteins
MS multiple sclerosis
ND neurodegenerative diseases
NMDA N-methyl-d-aspartate
OA oxidative stress
PA picolinic acid
PD Parkinson’s disease
PLP pyridoxal phosphate
PrPC cellular prion protein
PrPSc scrapie isoform of the prion protein
QA quinolinic acid
RANTES regulated upon activation, normal T cell expressed, and presumably secreted
RBC red blood cell
RNS reactive nitrogen species
ROS reactive oxygen species
SND stroke-induced secondary neurodegeneration
TDO tryptophan dioxygenase
TDP transactive response DNA-binding protein
TGF transforming growth factor
Th T helper
TNF tumor necrosis factor
Tregs regulatory T cells
TRP tryptophan
VEGF vascular endothelial growth factor
XA xanthurenic acid